Blood esinophils, FeNO, and the modifiable risk of asthma attacks
Recorded webinar
In Sanofi’s RespTalks webinar in January, Professor Ian Pavord & Dr. Simon Couillard discussed the concept of treatable traits as a new approach to managing asthma. In this recording, we hear Dr. Couillard presenting his views on how the treatable traits approach can aid the management of severe asthma.
.jpg/jcr:content/1607733024-ddb89e53704a97b213bb4d47eaec9440c380d160ed7b663830de6a32a4cd3df5-d%20(2).jpg)
Speaker: Simon Couillard, MD
Simon Couillard, MD, is a Canadian specialist in respiratory medicine and a clinical teacher at the Université de Sherbooke. He finished a two-year clinical research fellowship in severe asthma with the University of Oxford under the supervision of Professor Pavord, and has started a joint Oxford-Leiden PhD on risk prediction in asthma.
Previously broadcast RespTalks
Resptalks is a series of scientific webinars & podcasts on current topics related to respiratory diseases such as asthma, chronic rhinosinusitis with nasal polyps, to type 2 inflammation and much more.
Pour accéder à cette page, vous devez vous connecter. Si vous n'avez pas de compte, vous pouvez en créer un ici.
.png/jcr:content/jcr_content%20(55).png)
-(3).jpg/jcr:content/jcr_content%20(3)%20(3).jpg)
Les contenus accessibles par ce site sont destinés exclusivement aux Professionnels de Santé.
Les contenus accessibles par ce site sont destinés
exclusivement aux Professionnels de Santé.
Sanofi met a votre disposition, sur un portail unique dédié aux professionnels de santé, des contenus exclusifs comprenant des contenus scientifiques et des outils pour votre pratique quotidienne.